LUNG CANCER

>

Latest News

FDA Clears Phase 1 Study of TGW101 for Advanced Solid Tumor Treatment
FDA Clears Phase 1 Study of TGW101 for Advanced Solid Tumor Treatment

April 24th 2025

Phase 1 trial of TGW101 in advanced solid tumors is enrolling to assess safety and pharmacokinetics and define the maximum tolerated dose in up to 50 patients.

Ivonescimab Plus Chemo Shows Stronger NSCLC Response Than Tislelizumab Combo
Ivonescimab Plus Chemo Shows Stronger NSCLC Response Than Tislelizumab Combo

April 23rd 2025

Leighl Covers PALOMA-3 Trial of SC Amivantamab in NSCLC
Leighl Covers PALOMA-3 Trial of SC Amivantamab in NSCLC

April 18th 2025

Novel Radioenhancer JNJ-1900 Shows Potential Across Cancers
Novel Radioenhancer JNJ-1900 Shows Potential Across Cancers

April 15th 2025

Savolitinib/Osimertinib Yields Durable Responses in EGFR-Mutated, MET+ NSCLC
Savolitinib/Osimertinib Yields Durable Responses in EGFR-Mutated, MET+ NSCLC

April 14th 2025

Latest CME Events & Activities

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

Differentiating Adverse Events for Antibody-Drug Conjugates Across Solid Tumor Management

View More

Annual Hawaii Cancer Conference

January 24-25, 2026

Register Now!

42nd Annual CFS: Chemotherapy Foundation Symposium®: Innovative Cancer Therapy for Tomorrow

View More

<1
...
8586878889